Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's or Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03557619
What this trial is testing

Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

Who this might be right for
Hematologic Malignancies
AbbVie 12
Early research (Phase 1)Study completedNCT00002543
What this trial is testing

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+2 more
Medical College of Wisconsin 3
Testing effectiveness (Phase 2)Study completedNCT00201318
What this trial is testing

Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen

Who this might be right for
Non-Hodgkin's Lymphoma
National Health Research Institutes, Taiwan 50
Large-scale testing (Phase 3)UnknownNCT00028717
What this trial is testing

Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Commissie Voor Klinisch Toegepast Onderzoek 400
Testing effectiveness (Phase 2)Study completedNCT01685008
What this trial is testing

Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin Lymphoma
MorphoSys AG 92
Testing effectiveness (Phase 2)Ended earlyNCT04155840
What this trial is testing

Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Lymphoid LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+1 more
University of Washington 1
Testing effectiveness (Phase 2)Study completedNCT00090090
What this trial is testing

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Mantle Cell LymphomaChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Spectrum Pharmaceuticals, Inc 114
Early research (Phase 1)Active Not RecruitingNCT01479842
What this trial is testing

Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+7 more
Kami Maddocks, MD 48
Large-scale testing (Phase 3)Ended earlyNCT00714259
What this trial is testing

Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies

Who this might be right for
Multiple MyelomaCLL / SLLNon Hodgkin's Lymphoma+2 more
University of Alabama at Birmingham 5
Testing effectiveness (Phase 2)Study completedNCT00274924
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 100
Testing effectiveness (Phase 2)Study completedNCT03015896
What this trial is testing

Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Grade 3a Follicular LymphomaRecurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell Lymphoma+12 more
David Bond, MD 36
Testing effectiveness (Phase 2)Study completedNCT00081861
What this trial is testing

Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 13
Early research (Phase 1)Study completedNCT00572637
What this trial is testing

Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas

Who this might be right for
Solid TumorsLymphoma, Non-Hodgkin
Ethical Oncology Science 55
Early research (Phase 1)Ended earlyNCT00521638
What this trial is testing

Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, B-Cell
Wyeth is now a wholly owned subsidiary of Pfizer 120
Testing effectiveness (Phase 2)Study completedNCT00115193
What this trial is testing

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen 77
Testing effectiveness (Phase 2)Study completedNCT00670592
What this trial is testing

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's Lymphoma
Novartis Pharmaceuticals 111
Testing effectiveness (Phase 2)Study completedNCT00002471
What this trial is testing

Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06806033
What this trial is testing

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Who this might be right for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Hoffmann-La Roche 130
Large-scale testing (Phase 3)Study completedNCT00310167
What this trial is testing

Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University College, London 614
Early research (Phase 1)Looking for participantsNCT05370430
What this trial is testing

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
PeproMene Bio, Inc. 36
Next Page